Newton Biocapital Founded 2017
Founders Alain Parthoens
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 3
Average round size
info
The average size of a deal this fund participated in
$10M
Portfolio companies 3
Rounds per year 0.75
Lead investments 2
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.25
Exits -
Key employees -
Stages of investment
Early Stage Venture
Seed
Areas of investment
Biopharma
Finance
Health Care
Medical
Medical Device
Pharmaceutical
Summary

In 2017 was created Newton Biocapital, which is appeared as VC. The main office of represented VC is situated in the Brussels. The fund was located in Europe if to be more exact in Belgium.

The current fund was established by Alain Parthoens. The overall number of key employees were 7.

This Newton Biocapital works on 12 percentage points less the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2018. Considering the real fund results, this VC is 30 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 2-6 investment rounds annually. The top amount of exits for fund were in 2019. The common things for fund are deals in the range of 10 - 50 millions dollars.

Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - Belgium. Among the various public portfolio startups of the fund, we may underline DIM3, Synergia Medical, ChromaCure The fund has no specific favorite in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Project Management, Manufacturing.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Newton Biocapital, startups are often financed by VI Partners AG, Neomed Management, Entrepreneurs Fund. The meaningful sponsors for the fund in investment in the same round are S.R.I.W., SFPI-FPIM, CapDecisif. In the next rounds fund is usually obtained by Go Capital, CapDecisif, Anaxago.

Read more
Latest deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
Sequana Medical
Health Care
Manufacturing
Medical Device
Series D
10M16 Oct 2018 Switzerland, Zurich
Acticor Biotech
Biopharma
Biotechnology
Pharmaceutical
Therapeutics
Series B
8M06 Nov 2019 France, Paris
Acticor Biotech
Biopharma
Biotechnology
Pharmaceutical
Therapeutics
Series B
18M17 Oct 2018 France, Paris
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Newton Biocapital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: